Peleg L, Goldman B
Genetic Institute, Sheba Medical Center, Tel-Hashomer, Israel.
Eur J Clin Chem Clin Biochem. 1994 Feb;32(2):65-9. doi: 10.1515/cclm.1994.32.2.65.
The determination of hexosaminidases A and B in most programmes for Tay-Sachs disease carrier detection is based on their different heat sensitivity (hexosaminidase A is the heat labile isoenzyme). This routine cannot be employed for individuals who also possess a thermolabile hexosaminidase B. In Israel, 0.6% of the screened samples have a labile hexosaminidases B (about 110 each year) and the assessment of their hexosaminidase A activity has hitherto been based on isoenzyme separation by ion exchange chromatography. The latter requires relative large serum samples, and the individuals must usually be reappointed. In order to avoid the thermal treatment we have used the alternative technique, which employs two substrates with different specificities for the two isoenzymes: 1. The fluorogenic substance, 4-methylumbelliferyl-N-acetyl-glucopyranoside, which measures total hexosaminidase activity and 2. the derivative, 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate, which is considerably more specific toward hexosaminidase A. Hexosaminidase A activity was expressed as a ratio of total activities (the ratio of the assay with 4-methylumbelliferyl-N-acetyl glucosamine-6-sulphate to that with 4-methyllumbelliferyl-N-acetyl-glucopyranoside). Using the results from 65 obligate heterozygotes for Tay-Sachs disease, we established our reference ranges for assigning the genotypes with respect to the Tay-Sachs gene. Comparison of the results from 182 unrelated and randomly chosen sera screened by the ratio method and by heat inactivation, showed a very high correlation (r = 0.996). Sixty eight sera with thermolabile hexosaminidase B were tested by ion exchange chromatography and by the double substrate method, and they yielded identical diagnoses with regard to the Tay-Sachs locus.(ABSTRACT TRUNCATED AT 250 WORDS)
在大多数检测泰-萨克斯病携带者的项目中,对己糖胺酶A和B的测定是基于它们不同的热敏感性(己糖胺酶A是热不稳定同工酶)。对于同时拥有热不稳定己糖胺酶B的个体,此常规方法不适用。在以色列,0.6%的筛查样本有不稳定的己糖胺酶B(每年约110例),迄今为止对其己糖胺酶A活性的评估是基于通过离子交换色谱法进行同工酶分离。后者需要相对大量的血清样本,而且个体通常必须再次预约。为了避免热处理,我们采用了另一种技术,该技术使用对两种同工酶具有不同特异性的两种底物:1. 荧光物质4-甲基伞形酮基-N-乙酰-吡喃葡萄糖苷,用于测量总己糖胺酶活性;2. 衍生物4-甲基伞形酮基-N-乙酰氨基葡萄糖-6-硫酸盐,它对己糖胺酶A的特异性更强。己糖胺酶A活性表示为总活性的比率(用4-甲基伞形酮基-N-乙酰氨基葡萄糖-6-硫酸盐检测的结果与用4-甲基伞形酮基-N-乙酰-吡喃葡萄糖苷检测的结果之比)。利用65例泰-萨克斯病 obligate杂合子的结果,我们建立了关于泰-萨克斯基因分配基因型的参考范围。对182份通过比率法和热失活法筛查的无关随机选择血清的结果进行比较,显示出非常高的相关性(r = 0.996)。对68份具有热不稳定己糖胺酶B的血清通过离子交换色谱法和双底物法进行检测,它们在泰-萨克斯位点的诊断结果相同。(摘要截短于250字)